SCHEMBL2912544

SCHEMBL2912544

CCc1ccc(-c2cn(CCCNc3ccc([N+](=O)[O-])c(N)n3)cc2NC(=O)Cn2ccnc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.37
CDK1 P06493 1/20 0.37
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
QPCT Q16769 3/20 0.37
KDM4E B2RXH2 2/20 0.36
AHR P35869 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MAPT P10636 3/20 0.35
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MGLL Q99685 1/20 0.33
POLB P06746 1/20 0.33
HTT P42858 2/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2907512 0.88 GSK3A (0.32) CDK1GSK3AGSK3B
SCHEMBL2908407 0.87 GSK3B (0.34) CDK1GSK3AGSK3BNPSR1MAPT
SCHEMBL2907498 0.87 RAB9A (0.38) GSK3AGSK3BKDM4EMAPTALDH1A1
SCHEMBL2912527 0.86 GSK3B (0.36) CDK1GSK3AGSK3BKMT2A
SCHEMBL2904881 0.86 RAB9A (0.39) GSK3AGSK3BKDM4EMAPTALDH1A1
SCHEMBL2912926 0.86 BDKRB1 (0.34) GSK3AGSK3BNPSR1MAPTSMN1; SMN2
SCHEMBL2910394 0.85 KDM4E (0.39) GSK3BKDM4EAHRMAPTALDH1A1
SCHEMBL2911856 0.84 GSK3B (0.52) CYP19A1CDK1GSK3AGSK3BQPCT
SCHEMBL2913211 0.83 POLB (0.46) GSK3AGSK3BKDM4EALDH1A1L3MBTL1
SCHEMBL2903975 0.83 POLB (0.39) GSK3AGSK3BKDM4EALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed